Annual Total Liabilities
$36.06 M
-$7.21 M-16.67%
December 31, 2023
Summary
- As of February 7, 2025, JANX annual total liabilities is $36.06 million, with the most recent change of -$7.21 million (-16.67%) on December 31, 2023.
- During the last 3 years, JANX annual total liabilities has risen by +$5.20 million (+16.86%).
- JANX annual total liabilities is now -16.67% below its all-time high of $43.27 million, reached on December 31, 2022.
Performance
JANX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$38.91 M
+$5.18 M+15.35%
September 30, 2024
Summary
- As of February 7, 2025, JANX quarterly total liabilities is $38.91 million, with the most recent change of +$5.18 million (+15.35%) on September 30, 2024.
- Over the past year, JANX quarterly total liabilities has increased by +$1.01 million (+2.67%).
- JANX quarterly total liabilities is now -56.07% below its all-time high of $88.59 million, reached on March 31, 2021.
Performance
JANX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
JANX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.7% | +2.7% |
| 3 y3 years | +16.9% | +171.5% |
| 5 y5 years | +318.2% | - |
JANX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.7% | +167.2% | -12.0% | +210.9% |
| 5 y | 5-year | -16.7% | +318.2% | -56.1% | +223.5% |
| alltime | all time | -16.7% | +318.2% | -56.1% | +223.5% |
Janux Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $38.91 M(+15.4%) |
| Jun 2024 | - | $33.73 M(+1.5%) |
| Mar 2024 | - | $33.22 M(-7.9%) |
| Dec 2023 | $36.06 M(-16.7%) | $36.06 M(-4.9%) |
| Sep 2023 | - | $37.90 M(-9.8%) |
| Jun 2023 | - | $42.03 M(+0.8%) |
| Mar 2023 | - | $41.69 M(-3.6%) |
| Dec 2022 | $43.27 M | $43.27 M(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $44.24 M(+6.5%) |
| Jun 2022 | - | $41.55 M(+232.0%) |
| Mar 2022 | - | $12.52 M(-7.3%) |
| Dec 2021 | $13.50 M(-56.3%) | $13.50 M(-5.8%) |
| Sep 2021 | - | $14.33 M(+19.2%) |
| Jun 2021 | - | $12.03 M(-86.4%) |
| Mar 2021 | - | $88.59 M(+187.1%) |
| Dec 2020 | $30.86 M(+257.8%) | $30.86 M |
| Dec 2019 | $8.62 M | - |
FAQ
- What is Janux Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Janux Therapeutics?
- What is Janux Therapeutics annual total liabilities year-on-year change?
- What is Janux Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Janux Therapeutics?
- What is Janux Therapeutics quarterly total liabilities year-on-year change?
What is Janux Therapeutics annual total liabilities?
The current annual total liabilities of JANX is $36.06 M
What is the all time high annual total liabilities for Janux Therapeutics?
Janux Therapeutics all-time high annual total liabilities is $43.27 M
What is Janux Therapeutics annual total liabilities year-on-year change?
Over the past year, JANX annual total liabilities has changed by -$7.21 M (-16.67%)
What is Janux Therapeutics quarterly total liabilities?
The current quarterly total liabilities of JANX is $38.91 M
What is the all time high quarterly total liabilities for Janux Therapeutics?
Janux Therapeutics all-time high quarterly total liabilities is $88.59 M
What is Janux Therapeutics quarterly total liabilities year-on-year change?
Over the past year, JANX quarterly total liabilities has changed by +$1.01 M (+2.67%)